Tech Company Financing Transactions

Edimer Pharmaceuticals Funding Round

On 3/31/2012, Edimer Pharmaceuticals raised $5.7 million in financing from Third Rock Ventures.

Transaction Overview

Announced On
3/31/2012
Transaction Type
Venture Equity
Amount
$5,682,000
Round
Undisclosed
Investors

Third Rock Ventures (Cary Pfeffer)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
55 Cambridge Pkwy. 102W
Cambridge, MA 02142
USA
Email Address
Overview
Edimer is dedicated to developing EDI200 as a treatment for X-linked Hypohidrodic Ectodermal Dysplasia (XLHED). Learn more edimerpharma.com and XLHEDnetwork.com
Profile
Edimer Pharmaceuticals LinkedIn Company Profile
Social Media
Edimer Pharmaceuticals Company Twitter Account
Company News
Edimer Pharmaceuticals News
Facebook
Edimer Pharmaceuticals on Facebook
YouTube
Edimer Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Neil Kirby
  Neil Kirby LinkedIn Profile  Neil Kirby Twitter Account  Neil Kirby News  Neil Kirby on Facebook
VP - Operations
Ramsey Johnson
  Ramsey Johnson LinkedIn Profile  Ramsey Johnson Twitter Account  Ramsey Johnson News  Ramsey Johnson on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2012: Diagnovus venture capital transaction
Next: 3/31/2012: Banjo venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary